• 9F, Zhongrui Jumei Building, 68 Jiuzhang Road, Suzhou Industrial Park, Jiangsu Province

Boston Children's Hospital

Boston Children’ s Hospital, established in 1869, is a teaching hospital at Harvard University and has a high reputation among children's hospitals across the United States. The hospital has 10 pediatric specialties that rank among the top in the United States, including pediatric cancer, pediatric cardiac and cardiac surgery, pediatric gastrointestinal and gastrointestinal surgery, pediatric neurology, pediatric neonatology, pediatric kidney, pediatric orthopedics, and pediatric urology, which rank first in the United States, and pediatric endocrinology and pediatric pulmonary surgery, which rank second in the United States. For 140 years, we have been working hard for the treatment of childhood diseases, from successfully relieving leukemia in 1947 to correcting complex fetal heart defects.

In addition to Harvard Medical School, partners include the Harvard Stem Cell Institute, the Massachusetts Institute of Technology for Health Sciences and Technology, the Bode Institute, and Boston University, and maintain close partnerships with the Dana Farber Cancer Institute, Brigham and Women's Hospital, and Massachusetts General Hospital.

The hospital adheres to family centered therapy. Currently, there are 395 child beds, 15748 inpatients, 6795 inpatient surgeries and 19747 outpatient surgeries per year. The emergency room has received 58872 visits.

In addition, Boston Children's Hospital is also a large-scale research institution. The research team has more than 1300 scientists, including 7 members of the National Academy of Sciences, 12 members of the Medical Research Institute, and 14 Howard& middot; The Hughes Institute and 28 members of the American Society for Clinical Research. Research facilities include a basic and transformational research base covering an area of over 800000 square feet and a clinical research base covering an area of 50000 square feet. With an annual research investment of 308 million yuan, it has received a large amount of research investment from pediatric centers across the United States, aiming to provide unparalleled innovative treatment and technology for patients& nbsp;